Cost effectiveness of letrozole versus anastrozole in postmenopausal women with HR+ early-stage breast cancer

作者
Michael Lipsitz,Thomas E. Delea,Amy Guo
出处
期刊:Current Medical Research and Opinion [Taylor & Francis]
卷期号:26 (10): 2315-2328 被引量:7
标识
DOI:10.1185/03007995.2010.510784
摘要

BACKGROUND: The Breast International Group (BIG) 1-98 and Arimidex, Tamoxifen Alone or in Combination (ATAC) trials demonstrated that, in postmenopausal women with hormone receptor positive (HR+) early-stage breast cancer, 5 years of initial adjuvant endocrine therapy with letrozole or anastrozole is superior to tamoxifen. With expected generic availability of anastrozole in July 2010 and letrozole in June 2011, there may be financial pressures prior to letrozole's generic availability to start treatment-naïve patients on anastrozole vs. letrozole or to switch patients already receiving letrozole to anastrozole. METHODS: A Markov model was used to estimate cost per quality-adjusted life-year (QALY) gained with letrozole vs. anastrozole from the US healthcare system perspective. Cost effectiveness was examined separately in treatment-naïve patients and in patients already receiving letrozole. For the latter, cost effectiveness of continued letrozole vs. therapeutic substitution (TS) to generic anastrozole was evaluated separately in cohorts defined on years of endocrine therapy remaining. TS to generic anastrozole was assumed to result in an additional 5% of patients discontinuing endocrine therapy. Probabilities of distant recurrence and death were taken from reports of BIG 1-98, ATAC, the Early Breast Cancer Trialists' Collaborative Group meta-analysis of tamoxifen, and other published sources. Carry-over effects of aromatase inhibitors were assumed to be proportional to treatment duration. Costs of aromatase inhibitors were assumed to decline by 75% with generic availability. RESULTS: In treatment-naïve patients, total expected lifetime costs are $3916 greater with letrozole vs. anastrozole. However, initiation of treatment with letrozole results in a gain of 0.15 QALYs. Cost per QALY gained with letrozole vs. anastrozole is $25,846. In patients already receiving letrozole, the increase in total expected lifetime costs with continued letrozole vs. TS to anastrozole is between $4200 and $4500 in all cohorts. QALYs gained with letrozole range from 0.21 in those with 4 years of endocrine therapy remaining to 0.13 in those with 1 year of therapy remaining. Cost per QALY gained ranges from $20,276 to $34,356. CONCLUSION: For postmenopausal women with HR+ early-stage breast cancer, letrozole is more likely to be cost effective vs. anastrozole in treatment-naïve patients and in patients already receiving letrozole. Limitations of the study include a lack of direct evidence comparing letrozole and anastrozole and lack of data on rates of discontinuation due to therapeutic substitution with aromatase inhibitors.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
小胡发布了新的文献求助10
刚刚
胖胖橘发布了新的文献求助10
刚刚
Lumos完成签到 ,获得积分10
1秒前
HHH发布了新的文献求助10
2秒前
3秒前
3秒前
mm完成签到,获得积分10
4秒前
Cbbaby完成签到,获得积分10
4秒前
4秒前
七听发布了新的文献求助10
4秒前
4秒前
4秒前
5秒前
5秒前
DeepSleep完成签到,获得积分10
6秒前
慕青的应助被godman605采纳,获得10
6秒前
早日发文章完成签到,获得积分10
6秒前
Floy发布了新的文献求助10
7秒前
猫猫头沉迷装管子完成签到,获得积分10
7秒前
冰糖葫芦完成签到,获得积分10
8秒前
8秒前
霁月发布了新的文献求助10
8秒前
霁月发布了新的文献求助10
8秒前
霁月发布了新的文献求助10
8秒前
8秒前
HHH完成签到,获得积分10
9秒前
mm发布了新的文献求助10
9秒前
9秒前
香蕉觅云的应助被聪明冰蓝采纳,获得10
9秒前
要减肥含灵完成签到,获得积分10
9秒前
9秒前
六神曲完成签到,获得积分10
10秒前
10秒前
夕沫完成签到,获得积分10
11秒前
火星上静竹完成签到,获得积分10
11秒前
呼啦啦完成签到,获得积分10
11秒前
12秒前
13秒前
Maestro_S的应助被鲤鱼鑫磊采纳,获得10
13秒前
YXY完成签到,获得积分10
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8187362
求助须知:如何正确求助?哪些是违规求助? 9575478
关于积分的说明 21841431
捐赠科研通 7785067
什么是DOI,文献DOI怎么找? 3434943
关于科研通互助平台的介绍 2559401
邀请新用户注册赠送积分活动 2481820